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Abstract  
Neural tube defects (NTDs) are among the most common congenital defects with a 
high incidence of 1-2 per 1000 births, causing a heavy burden to both the families and society. 
Various types of NTDs result from defects happening in the neurulation process during 
vertebrate embryonic development. In order to prevent the occurrence of NTDs, understanding 
the underlying mechanism is a prerequisite. The etiology of NTDs is complex involving 
environmental and genetic factors. Folic acid supplementation was proven to efficiently 
decrease the frequency of NTDs by 50-70% depending on the time point of this 
supplementation and demographic background. Gene identification studies in NTDs have 
adopted mainly a candidate gene approach investigating folate-related genes and genes 
derived from animal models. In particular, studies in mouse models have demonstrated a 
strong association between the non canonical Wnt/Planar Cell Polarity (PCP) pathway and 
NTDs.  Protein Tyrosine Kinase 7 (PTK7) is a member of the PCP pathway and was shown to 
cause a very severe form of NTDs called craniorachischisis in a mouse model. Ptk7 
genetically interacts with a core PCP member Vangl2 where double heterozygotes suffer from 
spina bifida.  These data make PTK7 a strong candidate for NTDs in humans. We sequenced 
the coding region and the exon-intron junctions of PTK7 in a cohort of 473 patients affected 
with various forms of open and closed NTDs. Novel and rare variants (<1%) were genotyped 
in a cohort of 473 individuals. Their pathogenic effect was predicted in silico and functionally 
in an overexpression assay in a well established zebrafish model.  We identified in our cohort 
6 novel rare mutations, 3 of which are absent in all public databases, in 1.1% of our NTD 
cohort.  One variant, p.Gly348Ser, acted as a hypermorph when overexpressed in the zebrafish 
model. Our findings implicate mutation of PTK7 as a risk factor for NTDs and provide 
additional evidence for a pathogenic role of PCP signaling in these malformations. 
Keywords: Protein Tyrosine Kinase 7, neural tube defects, planar cell polarity, convergent 
extension, re-sequencing analysis, zebrafish model. 
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Résumé 
Les anomalies du tube neural (ATN) sont des anomalies développementales où le tube 
neural reste ouvert (1-2/1000 naissances). Afin de prévenir cette maladie, une connaissance 
accrue des processus moléculaires est nécessaire. L’étiologie des ATN est complexe et 
implique des facteurs génétiques et environnementaux. La supplémentation en acide folique 
est reconnue pour diminuer les risques de développer une ATN de 50-70% et cette diminution 
varie en fonction du début de la supplémentation et de l’origine démographique. Les gènes 
impliqués dans les ATN sont largement inconnus. Les études génétiques sur les ATN chez 
l’humain se sont concentrées sur les gènes de la voie métabolique des folates du à leur rôle 
protecteur dans les ATN et les gènes candidats inférés des souris modèles. Ces derniers ont 
montré une forte association entre la voie non-canonique Wnt/polarité cellulaire planaire (PCP) 
et les ATN. Le gène Protein Tyrosine Kinase 7 est un membre de cette voie qui cause l’ATN 
sévère de la craniorachischisis chez les souris mutantes.  Ptk7 interagit génétiquement avec 
Vangl2 (un autre gène de la voie PCP), où les doubles hétérozygotes montrent une spina bifida. 
Ces données font de PTK7 comme un excellent candidat pour les ATN chez l’humain. Nous 
avons re-séquencé la région codante et les jonctions intron-exon de ce gène dans une cohorte 
de 473 patients atteints de plusieurs types d’ATN. Nous avons identifié 6 mutations rares 
(fréquence allélique <1%) faux-sens présentes chez 1.1% de notre cohorte, dont 3 sont 
absentes dans les bases de données publiques. Une variante, p.Gly348Ser, a agi comme un 
allèle hypermorphique lorsqu'elle est surexprimée dans le modèle de poisson zèbre. Nos 
résultats impliquent la mutation de PTK7 comme un facteur de risque pour les ATN et 
supporte l'idée d'un rôle pathogène de la signalisation PCP dans ces malformations. 
 
Mots clefs: Protéine Tyrosine Kinase 7, anomalies du tube neural, polarité cellulaire planaire, 
extension convergence, analyses de re-séquençage, modèle poisson zèbre 
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1. Introduction 
1.1Neural tube defects 
1.1.1 Classification and clinical symptoms 
Neural tube defects (NTDs) are among the most common congenital defects of the 
central nervous system, affecting 1-2/1000 births. They are caused by complete or partial 
failure of the closure of the neural tube during neurulation [1]. NTDs comprise a wide array of 
morphologically distinct malformations. There are two types of NTDs according to the 
morphological appearance at birth. Open NTDs of which the brain and/or spinal cord are 
exposed and include anencephaly, craniorachischisis, encephalocele, anencephaly and spina 
bifida. In closed NTDs, the spinal defects are covered by skin and include lipomeningocele 
and tethered spinal cord. Within these distinct morphologically classified malformations, the 
clinical syndromes vary from mild to severe such as stillborn or immediate death after birth [2, 
3]. The following paragraph will discuss mainly the most common NTDs with their 
corresponding clinical symptoms. NTD happens following failure of neural tube closure. In 
both humans and mouse models, there exist multiple neural closure sites. The number and 
sites of neural tube closure in humans are not as clear as in mouse models [4].  
 
Anencephaly is a severe NTD resulting from failure of complete closure of the rostral 
end of neural tube during the third to fourth week of conception. It is characterized by absence 
of telencephalon and the exposure of the residues of brain tissue without the cover of skin and 
skull (Fig. 1B).  The affected babies are unconscious due to the absence of the telencephalon 
which is responsible for cognition and they cannot survive for long after birth. It is estimated 
to have an occurence about 1 in 10000 births in the United States. Due to the fact that many of 
these pregnancies result in miscarriage, this number might be underestimated [5]. Females 
babies are reported to be more affected than males [6]. 
 
 2 
 
 
Myelomeningocele also known as spina bifida affects the posterior region of the 
spinal cord (Fig.1 C). It is characterised by the opening of spinal cord mainly in 
the lumbar and sacral regions to varying extents. The clinical symptoms vary and include leg 
weakness and paralysis, orthopedic abnormalities and bladder and bowel control problems [8]. 
 
Craniorachischisis is characterized by an open neural tube in both cranial and spinal 
regions all along the body axis (Fig.1 D). It is the most severe type of NTDs with a relative 
low prevalence  leading to invariable death at birth [9]. 
 
Encephalocele is characterized by sac-like protrusions of the brain and the membranes 
that cover it through openings in the skull (Fig.1 E). The protrusion can happen in different 
regions along the cranial and forehead line. The clinical symptoms may include neurological 
 
 
Fig. 1. Representative NTDs and their defective sites in neural tube closure. A: Normal 
neural tube formation marked with 5 closure initiating sites. B: Anencephaly due to 
the failure of closure site 2. C: Spina bifida due to the failure of closure site 5. D: 
Craniorachischisis due to the failure of closure site 1. E: Encephalocele due to the 
failure of closure site 4 (it also can be due to defect of the closure site 2 or 3 and have 
this sac-like protrusion at different region). Adapted from Van allen et al, 1993 [7]. 
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problems, hydrocephalus, spastic quadriplegia, microcephaly, ataxia, developmental delay, 
vision problems, mental and growth retardation, and seizures. 
 
1.1.2 The epidemiology of NTDs 
NTDs have a world average prevalence of 1-2 per 1000 live births. The prevalence 
varies between different populations and different geographic regions. For example, the NTD 
prevalence is as high as 138.7 per 10,000 births in some areas in Shanxi province located in 
North China [10]. In England and Wales, the NTD prevalence declined from 5-6 per 1000 live 
birth in the 1950s to less than 1 per 1000 live birth in the 1990s due mainly to the increase in 
dietary folate intake and to peri-conceptional supplementation with folic acid [11]. The same 
declining trend was also demonstrated in North America [11]. Recurrence risks among women 
who have had an NTD-affected pregnancy are markedly higher (5%) than that in the first 
affected pregnancy in the general population (0.2%). And the risk would go up to 10% for the 
third pregnancy and 28% for the fourth pregnancy [12]. Concordance rates of monozygotic 
twins (7.7%) for NTDs exceeds that of dizygotic twins (4.0%) suggesting a genetic 
contribution [12]. 
 
1.1.3 Aetiology of NTDS 
The etiology of NTDs is complex involving environmental and genetic factors as 
suggested by epidemiological studies and genetic studies mainly conducted in animal models. 
Environmental factors associated with NTDs include folic acid insufficiency during the 
pregnancy, maternal obesity, maternal hyperinsulinemia and hot water exposure in the first 
trimester.  Previous pregnancy wastage and family history of NTDs are also considered as risk 
factors for NTDs [11]. Here, I will mainly discuss the role of folic acid in protection against 
NTDs and the genes associated with NTDs to date. 
 
1.1.3.1 Folic acid  
Folic acid (folate) is a form of the water-soluble vitamin B9. After absorption, it acts as 
an acceptor or donor of one-carbon units in a variety of reactions involved in amino acid and 
nucleotide metabolism, which is important for methylation, DNA synthesis and cell division. 
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A severe folic acid deficiency causes the macrocytic megaloblastic anemia characterized by 
many large immature and dysfunctional red blood cells in the bone marrow [13].  
 
The relation of folic acid to NTDs was revealed by epidemiological studies where it 
was confirmed that peri-conceptional intake of folic acid decreases both the recurrence rate  
among pregnancies following an NTD-affected pregnancy and the occurence rate in the 
general population [14]. It has been estimated that around 70% of human NTDs are 
preventable by adequate folate intake [15, 16]. Daily intake of 0.8 mg of folic acid as a 
vitamin supplement by pregnant women shows a significantly decreased occurrence of NTDs 
as compared to the control population (NTD cases in the number of  pregnancies: 0 in 2420 
versus 6 in 2333 with and without folate supplementation respectively in Caucasians [14]). 
 
The protective effect of folic acid against NTDs was confirmed by many subsequent 
observations or/and interventions conducted in distinct regions in the world. A study 
conducted in 1999 in China confirmed this preventive effect and at the same time showed that 
this effect is more marked in the region with high prevalence of NTDs than in the region with 
lower prevalence [17].  Food fortification is the practice of adding essential vitamins and 
minerals to staple foods to improve their nutritional content. A study conducted in Canada also 
showed that the prevalence of spina bifida decreased from 0.86/1,000 in the pre-fortification to 
0.40 in the full fortification period [18].  
 
Despite a well established protective effect of folate against NTDs, the underlying 
mechanisms remain unclear. Metabolic abnormalities of folic acid were suggested as one of 
the possible mechanisms  as studies demonstrated a link between levels of  maternal plasma 
and/or red cell folate level, plasma Vitamin B12, plasma Vitamin C (both are involved in the 
metabolism of folic acid), homocysteine and the risk of having fetuses affected with NTDs 
[19-24]. A study conducted on 81 women carrying NTD-affected fetuses during their 
pregnancies and 247 women carrying normal fetuses showed that both plasma folate and B12 
levels were significantly lower in women who were carrying affected fetuses than in controls 
[20]. The prevalence decreased from 6.6 per 1000 births in women whose red cell folate levels 
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were below 150 ng/ml (340 nmol/l) to 0.8 per 1000 births in women whose red cell folates 
were over 399 ng/ml (906 nmol/l) [21]. Homocysteine can be transformed to methionine with 
the help of Vitamin B12 while the 5-Methyl tetrahydrofolic acid (5-MTHF) is transformed to 
tetrahydrofolic acid (THF) in the same reaction. The relation of homocysteine with NTDs was 
first indicated where mothers of NTDs-affected children tended to have higher total plasma 
homocysteine as compared to controls with no NTD-affected children in the methionine 
loading test [22]. Higher amniotic fluid total homocysteine was also detected in the NTD case 
mothers and not in controls [23]. These results were further confirmed in pregnant woman 
carrying NTDs affected children and controls [24]. 
 
All these studies provide strong evidence for defects in the metabolism of folic acid in 
NTDs. Consequently, folate-related genes were investigated for involvement in NTDs by 
direct re-sequencing and association studies. The variant c.677C→T detected in 5,10 
methylenetetrahydrofolate reductase (MTHFR) that catalyzes the essentially irreversible 
conversion of 5,10-methyleneTHF to 5-methylTHF was the first folate-related genetic factor 
reported to be associated with NTDs.  It was shown that homozygous TT individuals carry a 
mildly higher plasma homocysteine concentration [25]. The T variant results in an enzyme 
that binds its cofactor flavin adenine dinucleotide (FAD) with lower affinity than the C variant. 
This affinity reduction can be compensated by addition of the cofactor FAD or by addition of 
folate, which explains why the elevated homocysteine levels seen in individuals homozygous 
for the TT variant can be partially reversed by riboflavin intervention [26-28]. Many genetic 
studies were conducted to find candidate variants in folate related genes, but the results were 
not as exciting as the original ones with many conflicts between different reports [29]. Clearly, 
additional studies are needed to better understand the relationship of folic acid metabolism and 
the occurrence of NTDs. 
   
1.1.3.2 Genetic factors in NTDs 
The evidence from epidemiological studies suggests a strong genetic contribution to 
the etiology of human NTDs [12]. Concordance rates of monozygotic twins (7.7%) for NTDs 
exceeds that of dizygotic twins (4.0%) [30]. 
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 The genetic contribution is also supported by the fact that NTDs are a feature (or 
symptom) of known genetic syndromes, such as trisomy 13, trisomy 18, and Meckel-Gruber 
syndrome [31]. Despite the strong evidence for a genetic component in NTDs, the major 
associated gene(s) or pathways have not been determined yet, mainly due to the complexity of 
the NTDs’ etiology.  At the same time, with the dramatic improvement in ENU (N-ethyl-N-
nitrosourea) mutagenesis and other transgenic techniques, many NTDs-related genes were 
identified from genetic studies conducted in mouse models [4]. These genes are involved in 
regulation of actin dynamics, cell adhesion, electron transport, DNA damage repair, and other 
processes [32, 33]. I will present a few examples of NTD genes identified in mouse models 
focusing mainly on planar cell polarity genes and their possible upstream and downstream 
effectors. 
 
The Loop-tail mouse is a well established mouse model for NTDs and is characterized 
by a looped tail phenotype in heterozygous mice, and craniorachischisis in homozygous 
embryos. The gene defective in Lp was identified as Vangl2 and is a mammalian ortholog of 
the Drosophila gene stbm/vang that forms part of the planar cell polarity (PCP) pathway 
controlling the convergent extension (CE) process in vertebrates which will be discussed later 
in section 1.3.2.2. Lp was the first mouse model to implicate PCP signalling in the 
pathogenesis of NTDs [34]. Since this study, many other mouse NTD mutants with PCP genes 
including Frizzled1, Frizzled3, Celsr1, Scribble1, Dishevelled1, Dishevelled3, and Protein 
tyrosine kinase7, were identified and showed various degrees of genetic interaction among 
them in the incidence of NTDs , confirming an important role of PCP signalling in 
development of NTDs [35-38]. Other potential downstream effectors of PCP signalling were 
also shown to cause NTDs in mice like Rho [39]. 
 
Canonical Wnt/β-catenin pathway and the non-canonical Wnt/ PCP pathway together 
regulate a lot of developmental processes including convergent extension. Dishevelled (Dsh), 
axin, and glycogen synthase kinase 3(GSK3) are involved in both pathways.  They are very 
important in keeping the balance between these two pathways [40]. 
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The human orthologues of PCP genes were investigated for their role in human NTDs 
by re-sequencing analyses of their coding regions. The first study that aimed at screening 
VANGL1 in human NTDs identified 3 novel rare missense mutations in this gene in 3 NTD 
patients: p. Val239Ile and p.Arg274Gln in 2 familial cases of NTDs and p.Met328Thr in a 
sporadic NTD case. Subsequent functional validation of these mutations using the yeast two 
hybrid system demonstrated that p.Val239Ile abolished interaction of Vangl2 with Dishevelled 
proteins and hence is most likely pathogenic [41]. The two variants p.Val239Ile and 
p.Met328Thr were also proven to be damaging in a zebrafish model where they failed to 
rescue a defective CE phenotype in zebrafish embryos injected with a morpholino 
oligonucleotide directed against Vangl2 [42]. Following these initial studies, larger studies 
conducted in larger cohorts of open and closed forms of NTDs have identified additional novel 
rare missense mutations in VANGL1 or VANGL2 associated with NTDs thereby confirming 
their role in these malformations. For VANGL1, 7 patients were heterozygous for 5 novel 
missense mutations, two of which, p.Ser83Leu and p.Arg181Gln, occurred in familial settings. 
Four mutations, p.Phe153Ser, p.Arg181Gln, p.Leu202Phe and p.Ala404Ser, were “private” 
and one mutation, p.Ser83Leu, was recurrent in 3 familial cases of tethered cord syndrome 
[43]. For VANGL2, six novel rare missense mutations were identified in 7 patients which are 
absent in the controls, five of which were detected in closed spinal NTDs [44].  
 
A study of another PCP gene, PRICKLE1, in the same cohort used in the above 
mentioned studies identified 7 rare missense heterozygous mutations that were absent from 
controls. Functional validation in zebrafish has demonstrated that one variant; p.Arg682Cys 
antagonized the CE phenotype induced by the wild-type zebrafish prickle1a in a dominant 
fashion [45]. Other PCP genes including CELSR1, FRIZZLED 6, DVL1 and DVL3 were also 
demonstrated to be associated with NTDs in a small fraction of patients. All these studies 
taken together confirm an important contribution of PCP genes to the occurrence of human 
NTDs. 
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CE is a process which is governed by many signalling pathways including PCP. The 
detailed morphological or molecular changes that occur in this process will be discussed later 
in section 1.3.2.2. To better understand the association of PCP genes with NTDs, I will 
describe the normal neural tube formation in the following section. 
 
1.2 Neural Tube Formation 
1.2.1 Neurulation in general  
Neurulation is an embryonic process by which the neural tube is transformed into the 
primitive structures that will later develop into the central nervous system. Neurulation in 
mammalian embryos occurs in two phases: primary and secondary neurulation [46]. These 
two phases occur in distinct areas along the rostro-caudal axis of the embryo. Primary 
neurulation happens on most of the axis from rostral end to the tail bud while the secondary 
neurulation is limited to the tail bud, which lies beyond the caudal neuropore. Primary 
neurulation occurs during the third and fourth weeks of pregnancy. It is the process by which 
the neural plate folds into the cylindrical neural tube leading to the formation of the brain and 
most of the spinal cord. Secondary neurulation occurs during the fifth and sixth weeks of 
pregnancy. It is the process by which mesenchymal cells in the dorsal part of the tail bud 
undergo condensation and epithelialisation (MET, mesenchymal–epithelial transition) to form 
the secondary neural tube which in turn forms the  lowest portion of the spinal cord including 
most of the sacral and all the coccygeal regions [47]. The lumen of the secondary neurulation 
is continuous with that of the primary neural tube.  
  
1.2.2 Primary Neurulation  
Primary neurulation can be subdivided into several stages: induction and formation of 
the neural plate, formation and elevation of the neural folds and closure of the neural groove 
(Figure 2) [48]. In each of these stages, specific tissue changes and specific molecules or 
genes are involved. Induction of the neural plate is mediated by some molecules secreted by 
primitive node that include Noggin, Chordin, Cerberus, Xnr3, Follistatin, Frzb, and eFGF [49]. 
These molecules suppress the default epidermal fate of the naive neural ectoderm by inhibiting 
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the BMPs and Wnts signals. After the induction, the formation of the neural plate is 
autonomous without the signalling from the surrounding epidermal ectoderm [50]. Then the 
neural plate conducts a CE morphogenetic process to narrow and elongate the neural axis in 
the mediolateral and rostro-caudal axes. This process will be discussed in detail in Section 
1.3.2.2.  At the same time the neural progenitor cells in the neural plate undergo apical 
constriction that would lead to changes in  cell shape from cuboidal to columnar and finally to 
wedge- or bottle-like while the cell volume keeps constant [51, 52]. Combining with the 
extrinsic forces generated by the CE movement in non-neural ectoderm, the intrinsic forces 
generated from the shape change initiate the bending of the neural plate [53, 54]. A groove is 
formed during this bending and finally develops the lumen of the neural tube after its closure. 
After its closure, the neural tube is separated from the overlaying epidermal ectoderm, which 
will further develop in to the skin of the back of the embryo. At this stage, another important 
cell population called neural crest cells and located between the neural tube and the epidermal 
ectoderm starts to migrate and finally develops into  various tissues in different structures [48].  
 
Closure of the neural tube groove is initiated at some specific sites and then elongates 
uni-directionally or bi-directionally to meet with the elongation from another site leading to 
complete closure of the whole neural tube. It is well established that there are multiple 
initiation sites for neural tube closure in both humans and mouse models, but the exact number 
of these sites is still undefined [4, 7]. For example in mouse models, 3 main distinct initiation 
sites along the neural axis are thought to function in a temporal and spatial-specific pattern to 
complete neural tube closure while in humans there are probably 5 sites [7]. Defects 
happening in these different initiation sites or in the elongation region of these sites will result 
in various NTD types [1, 7]. The representative NTDs and the corresponding closure defects 
are shown in Fig1.  
 10 
 
 
 
Fig. 2. Transverse sections for neural tube formation. Neural plate is induced by 
notochord under it (A). Neural folds form and elevate to create the neural 
groove (B). Bending or hinge points form at two sites: the dorsolateral hinge 
points (a) at the lateral extremes of the neural plate and the median hinge point 
(MHP) (b) overlying the notochord. With continued bending, the neural tube is 
closed and separates from the presumptive epidermis while the neural crest 
form and migrate to lateral sides. noc, notochord; np, neural plate; nf, neural 
fold; ng, neural groove; nt, neural tube; nc, neural crest; pe, presumptive 
epidermis.  
Adapted from http://instruct.uwo.ca/anatomy/530/anfound.htm. 
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The major morphogenetic changes in cell shape or movement are caused by 
cytoskeletal rearrangements (Fig.3). Actin filaments (F-actin) constitute a major component of 
the cytoskeleton that is composed of monomeric actin (G-actin). It is present at the apical 
junction of the neural plate cells in the form of circular bands. During the neural tube closure 
process, the band thickens leading to apical constriction (Fig. 3C) [55, 56]. Another essential 
cytoskeletal component is myosin II that also contributes to the apical constriction [57]. 
Myosin II is composed of two heavy chains, two essential light chains and two regulatory light 
chains. The activity of myosin II is regulated through phosphorylation of its regulatory light 
chain (rMLC) mainly by Rho-associated kinase (ROCK), an effector of the small GTPase Rho. 
Myosin II is co-localized with F-actin in the apical side of neural plate cells (Fig. 3C) [58]. 
Either the disruption of F-actin or inhibition of Myosin II activity can cause the disappearance 
of the apical constriction and failure of neural tube closure in chick embryos [39, 56, 58]. This 
causative relationship was also observed in Xenopus in which the expression of myosin II was 
reduced by a morpholino oligonucleotide (MO) leading to failure of the F-actin accumulation 
and apical constriction [58]. Microtubules are involved in the cell elongation during the 
neurulation process. Consistent with the shape changes of the neural plate cells from cuboidal 
to columnar; the microtubules are reorganized from random distribution and disorientation 
throughout the cells to a parallel orientation to the axis of elongation (Fig. 3A, B, C) [56, 59]. 
It was shown that the neuroepithelial cells treated with microtubule polymerization inhibitors 
prior to the elongation process failed to elongate in chick embryo. In shroom3 mutants and 
MO-injected embryos, apical constriction is significantly inhibited, associated with  a severe 
reduction in apical accumulation of F-actin and phosphorylated MLC (pMLC) [60]. In 
addition to intracellular molecules, cell adhesion molecules such as N-cadherin and nectin-2 
also play crucial roles in cellular morphogenesis during neural tube closure (Fig. 3C). All 
these studies demonstrate that cytoskeletal rearrangements generate the driving force for 
shaping the neural plate cells and closure of the neural tube. The molecular mechanisms 
involved in these rearrangements still remain poorly defined.   
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Fig. 3. Schematic diagram of cytoskeleton rearrangements in neural tube formation. In 
cuboidal neuroepithelial cells prior to neurulation (A), F-actin exists in a thin circular 
band (red) at apical junction, while microtubules (green) are diffusively distributed in 
cytoplasm. During cell elongation, non-centrosomal γ-Tubulin particles (yellow) are 
distributed apically while microtubules polymerize and assemble parallel to the 
apicobasal axis (B).  During apical constriction, actin filament bands constrict and 
become thickened. Non-muscle myosin II (green) actively slides and generates contractile 
force along apical actin filaments. The molecules that are accumulated at the apical 
junctions are shown in the circle while the adhesion molecules crucial for this 
constriction are marked besides.  Adapted from Suzuki M et al, 2012 [60]. 
 
 
1.2.3 Secondary Neurulation 
Secondary neurulation is initiated immediately after completion of the primary 
neurulation in the most posterior part of the caudal axis. Distinct from the primary neurulation, 
there is no neural plate formation or neural folds elevation. As indicated in Fig. 4, the bilateral 
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mesenchymal cells under the epithelial ectoderm undergo a mesenchymal-to-epithelial 
transformation (MET) characterized by a series of changes in the cell surface oligosaccharide 
complement of the differentiating cells. These cells together with the undifferentiated central 
mesenchymal cells migrate at the same time to form the cell mass located in the midline [61]. 
This is followed by formation of small cavities at the boundary between the two cells’ 
populations. These cavities enlarge while the central cells intercalate with the peripheral cells, 
and merge with each other resulting in a single lumen which becomes continuous with the 
neurocoele of the primary neural tube [61]. Developmental defects in this process are 
associated with closed spina bifida where the developing neural tube fails to separate from 
other tissues of the tail bud [62]. 
 
MET is the reverse process of epithelial–mesenchymal transition (EMT). Unlike 
epithelial cells which are stationary and characterized by an apical-basal polarity, tight 
junctions, and expression of cell-cell adhesion markers, mesenchymal cells do not have these 
mature cell-cell contacts and can invade the extracellular matrix. This transformation is very 
well studied in kidney ontogenesis, somitogenesis and cancer. The mechanisms by which the 
mesenchymal cells conduct this transformation are unknown. Some changes in gene 
expression patterns were reported during this transformation [63]. For example, Sox2 
expression is not detected in the mesenchymal cell mass at the beginning of secondary 
neurulation and become detectable at later stages in a cell cluster in the medullary cord which 
is the precursor of the neural tube. A similar pattern was observed for other epithelial apical-
basal polarity markers such as laminin and fibronectin (basal markers), N-cadherin and 
atypical protein kinase C (aPKC) (apical markers). At the same time, it was shown that these 
markers also propagate in dorsal to ventral orientation [63]. Activity levels of Rho family 
GTPases Rac1 and Cdc42 were also shown to be critical for the MET during secondary 
neurulation. 
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Fig. 4. Schematic diagram of secondary neurulation.  The bilateral mesenchymal cells 
under the epithelial ectoderm (A) proliferate, migrate and finally condensate at the 
midline (B, C). The condensed mesenchymal cells undergo MET and transformed to be 
neural epithelial cells (D). At the same time, small cavities starts to form inside the cell 
mass (D).  Finally the neural tube lumen formed with the complete neural epithelial 
cells transformation (E). me, mesenchymal cells.  ep, epithelial cells. nt, neural tube. nc, 
notochord. Adapted from: http://scienceblogs.com/pharyngula/2008/01/02/neurulation-
in-zebrafish/. 
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1.2.4 Neurulation in Zebrafish 
As zebrafish (Danio rerio) will be used in our study as an animal model, I will point 
out some specific characteristics of the neurulation process in zebrafish. Neurulation in 
zebrafish tail is conducted through secondary neurulation as in other vertebrates. Whether the 
neurulation in the head and trunk (Fig. 5) goes through primary or secondary neurulation is 
still in dispute. The process of this neurulation does not start from the condensation of 
mesenchymal cells in the midline as in traditional secondary neurulation. Instead, it starts from 
the columnarization of neural plate cells. A solid neural keel is formed by the accumulation of 
these columnarized neural plate cells. A solid neural tube (neural rod) will be formed 
following the separation of the neural keel from the originating neural plate. The lumen will 
appear after the solid neural tube goes through the cavitation process [64]. 
 
1.3 Wnt signalling pathways  
The Wnt members are secreted glycoproteins which can bind to different membrane- 
anchored receptors to activate multiple important pathways including canonical and non-
canonical signalling pathways. The determinant of which pathway will be activated has been 
recently suggested to be the different Wnts and different co-receptor crossbinding [65].  Wnt 
signalling functions in cell proliferation, stem cell maintenance and cell fate decisions, as well 
as organized cell movements and the establishment of tissue polarity in one layer. It is also 
known to be related to human cancers and degenerative diseases, mainly by activation of 
canonical and non-canonical Wnt pathways [65].  
 
The NTD phenotypes were observed in mouse mutants of genes involved in canonical 
(Wnt3 and  Lrp6) as well as non-canonical Wnt signalling (Vangl2 and Ptk7) [66].  This 
suggests that the balance between these two pathways is very critical to the neurulation 
process.  
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1.3.1 Canonical/β-catenin Wnt pathway 
The core member in the canonical Wnt pathway is β-catenin, which is constantly 
synthesized and then degraded through phosphorylation and ubiquitination  by a so-called 
destruction complex consisting of the scaffolding protein Axin, APC (adenomatous polyposis 
coli), GSK3 (Glycogen synthase kinase-3) and CK1 (casein kinase 1) (Fig. 6) [67]. Without 
the stimulation by Wnts, β-catenin is constantly degraded by this destruction complex. Once 
 
 
Fig. 5. Schematic diagram of neurulation in zebrafish.  The neural plate folds inward at 
the midline (A,B) and form the neural keel,  the keel progressively rounds up, forming 
the neural rod (C) without a lumen inside while the cells from lateral fuse to form the  
epidermal layer . Cavitation starts from the ventral side of the neural tube to the dorsal 
side finally forming the neural tube (D). np, neural plate; nc, notochord; nk, neural keel; 
nr, neural rod, nt,  neural tube.                                                                                  Adapted 
from: http://scienceblogs.com/pharyngula/2008/01/02/neurulation-in-zebrafish/. 
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the appropriate Wnt like Wnt3 or Wnt8 binds to the right Frizzled receptor, with the presence 
of other co-receptors like Lrp5/6 (low density lipoprotein receptor 5 or 6), Dsh is recruited to 
the membrane followed by its phosphorylation and this leads to disassembly of the destruction 
complex. β-catenin is then released from the complex, accumulates in the cytoplasm and then 
translocates into the nucleus. By relieving TCF/LEF (T-cell factor/Lymphoid enhancer-
binding factor ) from binding with transcription repressor Groucho, Wnt functions as a 
transcriptional activator and targets gene expression [65]. Canonical Wnt/β-catenin pathway is 
proven to function in cell proliferation, stem cell maintenance and cell fate decisions [68]. 
Defects in this pathway are responsible for tumorigenesis and developmental defects. β-
catenin  was  found to be mutated and causing hyperactivation of Wnt/β-catenin signalling in 
virtually  all intestinal cancers and other malignancies. In Drosophila, the mutation of Wnt1 
homolog Wingless causes a segment polarity defect [ 66, 69].  
 
There are disputed findings about the direct stream of Wnt, β-catenin, TCF/LEF, target 
gene activation pathway [70]. For example, TGF-β can also regulate the nucleus translocation 
of β-catenin independent of Wnts. Blocking the transcription activity of TCF could not block 
all the phenotypes induced by canonical Wnt ligands indicating another branch of downstream 
effectors besides TCF/LEF [70]. However, another group show that a dominate negative form 
of TCF4 abrogates DNA recruiting by any of the known transcription factors [71]. 
 
1.3.2 Non-canonical Wnt pathway  
1.3.2.1 The planar cell polarity (PCP) pathway 
1.3.2.1.1 PCP members 
The PCP pathway was first demonstrated in Drosophila and is highly conserved in 
vertebrates [72, 73]. It shares some common members with canonical/β-catenin Wnt pathway 
like Fz and Dsh (Fig. 6). Genetic studies of a wide range of mutants affecting some highly 
organized structures in the fly, like the distal orientation of wing hairs, the posterior 
orientation of the abdominal bristles and the more complex organization of the ommatidia (eye 
units) in the adult eye, have identified a group of so-called core PCP genes required for PCP 
signalling in all tissues and which include: Frizzled (Fz), Dishevelled (Dsh/Dvl), 
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Strabismus/Van Gogh (Stbm/Vang), Flamingo (Fmi), Prickle (Pk) and Diego (Dgo) [73-75]. 
In planar cells, PCP members are asymmetrically localized at the cell membrane: Fmi, Fz, Dsh, 
and Dgo localize to the distal region of the cell, whereas other PCP members Fmi, Vang and 
Pk localize to the proximal region. After Dsh recruitment to the membrane under the 
stimulation of some non-canonical Wnt activators (Wnt4, Wnt5a and Wnt11), PCP signalling 
through unknown mechanisms, lead to activation of the small GTPases RhoA and Rac, 
resulting in modification of the cytoskeleton like the contraction of F-actin and microtubule 
reorganization (Fig. 6). This modification ultimately results in the polarization of cells within 
epithelia and polarized cell migration [75, 76].  
 
1.3.2.1.2 PCP and convergent extension 
PCP signalling is essential to a morphogenetic pathway called CE during gastrulation 
and neurulation in vertebrates. CE is the process by which cells move from the lateral side to 
the midline and intercalate with each other giving rise to a longer and narrowed anterior –
posterior axis (Fig. 7) [65]. CE is a major driving force for neural tube formation and closure. 
In Vangl2 mutant Loop tail mice, the NTD phenotype craniorachischisis was demonstrated to 
be the result of a defective CE process manifested by a shorter anterior-posterior axis and 
wider left-right axis [77]. These CE defects were also observed in other PCP mutant mice 
models like Crash (Celsr1), Dvl1/Dvl2 double knockouts, Fz3/ Fz6 double knockouts, Circle 
tail (Scribble1) and  Chuzhoi (Ptk7) [32]. 
 
1.3.2.1.3 PCP signaling and ciliogenesis 
 
Cilia are microtubule-based protrusions on the surface of most vertebrate cells. There 
are two types of cilia: motile cilia and non-motile cilia (primary cilium). It is well known that 
motile cilia beat in coordinated waves to sweep mucus out of the respiratory tract or move the 
ovum from the ovary to the uterus [78]. The function of primary cilium was first illustrated to 
be linked to patterning of the mouse embryo by transducing Hedgehog signaling [79]. The 
mouse mutants show phenotypes characteristic of Hedgehog signaling defects including an 
open neural tube on the head and preaxial polydactyly. Following this, additional studies 
confirmed the role of cilium in inducing rostral neural tube defects [80, 81]. In humans, genes 
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involved in ciliogenesis are proven to be responsible for some Meckel-Gruber syndrome that 
typically involves meningo-encephalocele, polycystic kidneys and postaxial polydactyly [82, 
83]. In contrast to cilia mutants, PCP mutants are more affected with caudal neural tube 
defects [84]. Inversin,  a homolog of the PCP member Diego in fruit fly, was more studied in 
the context of ciliogenesis and was responsible for some renal cystic diseases [85]. Reduced 
expression of either PCP effectors Inturned or Fuzzy generated rostral neural tube closure 
defects [86]. 
 
PCP was shown to regulate the orientation of cilium in both individual cells and at the 
tissue level of radial glial cells and ependyma to create a coordinated beating [87]. Additional 
studies are needed to better understand the relationship between PCP members and cilium 
polarity and relationship between PCP members and Hedgehog signaling. 
 
1.3.2.2 Wnt/Ca2+ pathway  
The Wnt/Ca2+ pathway is another major non-canonical Wnt pathway.  There is 
crosstalk between the Wnt/Ca2+ pathway and the canonical β-catenin pathway or PCP pathway 
at different levels [88]. Wnt/Fz ligand receptor binding leads to a transient  increase  of certain 
intracellular signaling molecules, inositol 1,4,5-triphosphate (IP3), and 1,2 diacylglycerol 
(DAG). IP3 causes release of Ca2+ from ER (endoplasmic reticulum). Calcium ions in the 
presence of calmodulin or DAG can activate CaMKII (calcium calmodulin dependent protein 
kinase II) or protein kinase C (PKC). CaMKII and PKC can activate nuclear transcription 
factors (NFkB and CREB). Calcium can also activate phosphatase calcinurin (Cn) that can 
further activate nuclear factor associated with T cells (NFAT) (Fig. 6). These activated nuclear 
factors will regulate the expression of various genes related to development, cancer, and 
cellular responses as a consequence of inflammatory challenges. The Wnt/Ca2+ signaling 
pathway was proved to promote ventral cell fate through CaMKII during early embryogenesis 
in Xenopus [89]. 
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Fig. 6. Schematic model of Wnt pathways.  Canonical Wnt ligands bind to the 
membrane receptor Fzd forming a complex with some known and unknown co-
receptors like Lrp5/6. The subsequent Dvl membrane recruitment and interaction 
with Axin induce the disassembly of the β-catenin degradation complex. The free 
β-catenin accumulates in the cytoplasm and enters in the nucleus to activate the 
transcription of canonical target genes via an association with the DNA binding 
factors LEF/TCF. Non–canonical Wnt ligands bind to Fz with the help of co-
receptors and recruit Dvl to the membrane. Small GTPase family members Rac/ 
Rho are activated and regulate the cytoskeletal reorganization. The core PCP 
members Vangl, Diversin, Prickle, and Ceslr are all involved in the Dvl membrane 
localization. Diversin at the same time regulates the degradation of β-catenin. 
Wnt/Fz ligand receptor interaction with co-receptor Ror1/2 leads to the production 
of IP3 and DAG from phospholipid phosphatidyl inositol 4, 5-bisphosphate (PIP2).  
IP3 causes release of Ca2+ from ER; Cn and CamKII are activated which in turn 
activate NFAT and NFkB. DAG is activated by released calcium from ER, which 
activates PKC. PKC activates NFkB and CREB which together with NFAT will 
regulate downstream gene expression. Dotted arrows show the pathway direction; 
Green lines show the genetic or physical interaction between two proteins. The red 
line shows the binding that can inhibit the non-canonical pathway. 
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1.4 Protein Tyrosine Kinase 7  
1.4.1 The structure of Protein Tyrosine Kinase 7  
The first study on Ptk7 involved the cDNA coding of KLG that is the homolog of Ptk7 
in chicken  [90]. Human PTK7 and mouse Ptk7 were subsequently cloned [91, 92]. The human 
PTK7 gene is located to chromosone 6 and its coding region consists of 20 exons (NCBI Gene 
ID: 5754; Ensembl ID:  ENST00000230419). Among multiple splicing transcripts, the longest 
isoform encodes a protein composed by 1070 amino acids (Fig. 8, upper panel) [93]. Human 
PTK7 is a highly conserved single pass transmembrane protein that consists of one signal 
peptide which targets the protein to the membrane, seven extracellular Ig-like 
(immunoglobulin-like) domains and one cytoplasmic tyrosine kinase homolog domain which 
 
 
Fig. 7. Schematic diagram for convergent extension. The polarized cells lining the 
lateral side (green and light blue) migrate to the midline. Cells intercalate to each 
other resulting in narrowing in the medial-later axis and extending in the anterior –
posterior axis. M, midline; L, lateral line; A, anterior; P, posterior.  
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lacks kinase activity due to the absence of the DFG triplet which is essential for kinase activity 
(Fig. 8, lower panel ).  
 
 
1.4.2 The expression pattern of Ptk7 during embryonic development 
 In mouse embryos, at E6.5, Ptk7 is expressed in the early primitive streak. At E7.5, 
Ptk7 is broadly expressed throughout the embryo, with high levels in the primitive streak. At 
E8.25-E8.75, Ptk7 is highly expressed in the anterior and posterior regions of the primitive 
streak which is consistent with a role for Ptk7 in neural tube closure [35]. In Xenopus, Xptk7 is 
expressed in the neuroectoderm from late gastrula through all neurulation stages [35]. 
    
In zebrafish, Ptk7 expression is ubiquitous at the shield stage and is pronounced in 
axial, paraxial and tailbud regions during late-gastrula stages. In the post-gastrulation stage, 
Ptk7 is expressed in the head, neural tube and somites, with the highest level of expression 
 
 
Fig. 8. Schematic digrams of the structures of the PTK7 gene and its encoded protein. In 
the upper panel, each square stands for one exon where a different color is consistent 
with the domain that it codes for. On the lower panel, each oval stands for one domain 
whereas the TM domain is marked by a grey column. TM, transmembrane; Ig, 
immunoglobulin-like; Inactive PKD, inactive protein tyrosine kinase domain. 
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observed in the tailbud which persists until 24 hpf. The expression pattern of zebrafish ptk7 is 
similar to that observed in Xenopus and mouse [94]. 
 
1.4.3 PTK7 and NTDs 
The role of Ptk7 in embryonic development ranges from axon guidance in Drosophila 
to the regulation of gastrulation, neural tube closure, neural crest migration, cardiac 
morphogenesis and epidermal wound repair in vertebrates [95]. Here I will mainly focus on its 
role in neural tube closure. Ptk7 was first identified as an NTD responsible gene in a gene 
trapping screen for transmembrane proteins important for neural development.  Mutant mice 
that were homozygous for a truncating mutation in Ptk7 suffered from craniorachischisis that 
resulted from failure of neural tube closure initiation site 1. Besides the defects in the neural 
tube, the orientation of stereocilia bundles in the organ of Corti was also disrupted in these 
mice. Craniorachischisis and stereocilia orientation defects were also observed in Vangl2 and 
mScrib1 mutants (Lp and Crc, respectively). A strong genetic interaction was detected 
between Ptk7 and Vangl2 (Lp) where the frequencies of NTDs in the form of spina bifida 
increased dramatically from less than 10% (Lp/+) or zero (Ptk7/+) to 94% in double 
heterozygotes. No genetic interaction was observed between Crc and Ptk7. However, the NTD 
phenotype in Lp/+; Ptk7/+ double heterozygotes was not as severe as in Lp/+; Crc/+ double 
heterozygotes. The disruption in sensory hair cells orientation was also not observed in the 
Lp/+; Ptk7/+ double heterozygotes. 
 
Chuzhoi is an ENU-induced mutant which exhibits craniorachischisis and bundle 
orientation disruption in the inner ear. Abnormal lung and heart development were also 
observed in chuzhoi mutants. Genetic mapping and subsequent cloning showed that the 
underlying mutation in chuzhoi is a nucleotide substitution in Ptk7 that created a new splice 
acceptor site leading to a 3 amino acid insertion in the protein, thereby resulting in disruption 
of Ptk7 protein expression in chuzhoi mutants. Chuzhoi was also shown to genetically interact 
with Vangl2/Lp and Celsr1/Crsh but not with Scrib/Crc [96].  
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In the frog model, reduced expression of Xptk7 by MOs (morpholino oligomers) also 
causes NTDs. This phenotype could be rescued by co-injection of full-length Xptk7 or a 
construct lacking the cytoplasmic domain, indicating an important role of the membrane 
anchored extracellular domain in neural tube formation [35]. 
 
1.4.4 PTK7 and the Wnt pathways 
Recruitment of Dsh to the membrane is essential for the activation of both canonical 
and non-canonical Wnt pathways. The pseudokinase domain of Ptk7 is required for this 
recruitment. Loss of function of Fz7 does not affect Ptk7-mediated Dsh localization in animal 
caps. Interestingly, while overexpression of Fz7 leads to recruitment and phosphorylation of  
Dsh, overexpression of Ptk7 can recruit co-overexpressed Dsh to the membrane but no 
phosphorylated band was observed [97]. Rack1 is required for Ptk7-mediated Dsh membrane 
recruitment and the pseudo kinase domain of Ptk7 is necessary for Rack 1 translocation to the 
membrane. Furthermore, expression of a fusion construct consisting of a pseudo kinase 
domain-deleted mutant and Rack1 recruits Dsh to the membrane successfully suggesting that  
the pseudo kinase domain functions by recruiting Rack1 which in turn  recruits Dsh 
independent of Fz [98]. These results seem to be inconsistent with the study of Lu et al. (2004) 
that demonstrated this domain to be dispensable in rescuing the NTD phenotype induced by 
injection of MOs against Xptk7 in n the frog model. This inconsistency could be due to the use 
of different functional assays: overexpression in cell lines versus a MO-knockdown in the frog. 
Alternatively, Ptk7 is a highly versatile protein implicated in many biological processes and 
hence recruitment of Dsh by its pseudo-kinase domain could reflect a functional aspect that is 
independent of PCP signaling.  
 
Ptk7 co-precipitates with canonical Wnt3a and Wnt8 but not Wnt5a or Wnt11, 
indicating a role in canonical Wnt signalling [99], but Ptk7 inhibits rather than activates 
canonical Wnt activity.  In Xenopus, Ptk7 inhibited secondary axis formation induced by Wnt8 
or Wnt3a. The inhibition was also shown by siamois reporter assay which is readout of 
canonical Wnt pathway. The inhibition by Ptk7 is suggested to be upstream of β-catenin and 
Dsh. The non-canonical pathway was shown to be activated by Ptk7 through ATF2-based 
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luciferase reporter assay which is readout of the PCP pathway. For both the inhibitor and 
activator roles of Ptk7 in Wnt signalling, membrane-anchored extracellular part was shown to 
have the same activity as the full length one while the extracellular part alone or membrane-
anchored intracellular part lost this inhibition or activation effect, indicating a crucial 
regulatory role of the membrane anchored extracellular domain of Ptk7 in canonical and non-
canonical Wnt signalling. Ptk7 was suggested to act as a “molecular switch” that activates the 
Wnt/PCP non canonical pathway while inhibiting at the same time the Wnt/β-catenin 
canonical pathway [99]. One contradictory study showed that Ptk7 physically interacts with β-
catenin in a yeast two hybrid system and can activate the canonical Wnt pathway stimulated 
by Wnt3a. In the same study, they also showed that Ptk7 functions upstream  of the β-catenin 
destruction complex in the Wnt canonical signalling pathway probably by stabilizing β-
catenin [100]. 
 
 A recent study confirmed the role of ptk7 in zebrafish in both Wnt pathways and 
showed that this gene is also implicated in tailbud tissue differentiation. Overexpression of 
ptk7 induces the expansion of dorsalization marker chd and the reduction of ventralization 
marker vox and β-catenin target axin2. Co-injection of zebrafish ptk7 rescued the dorsoventral 
patterning defects induced by ectopic expression of wnt8. ptk7 genetically interacts with 
Wnt5b in body length reduction caused by defective CE. Wnt11-induced cyclopia was also 
shown to be potentiated by ptk7 overexpression [94]. In the same study, a mutant line made by 
a specifically engineered ZFN (zinc finger nuclease technology) showed that CE defects were 
observed in maternal-zygotic mutants, while this phenotype was absent in zygotic mutants 
demonstrating its important role in early embryo development [94].  Recently, another study 
by the same group described a skeletal defect observed in the zygotic mutant adult fish and 
demonstrated that this zebrafish model is an ideal model for idiopathic and congenital 
scoliosis [101]. One PTK7 mutation found in a scoliosis patient was shown to disrupt both 
PCP and Wnt/β-catenin signalling. 
 
Lrp6 (Low-density lipoprotein receptor-related protein 6), a single-pass transmembrane 
protein, is required in Wnt/β-catenin signalling and acts as a co-receptor for Wnt [102].  
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Dickkopf-1 (Dkk1), a secreted protein, negatively modulates the Wnt/β-catenin pathway 
through its binding to Lrp6 [103].  The role of Dkk1 in modulating the canonical and non-
canonical Wnt pathway was shown to be executed through the binding to Lrp6 or another 
membrane receptor Knypek (Kny) [104]. Lrp6 alone was also shown to be acting as a 
canonical and non-canonical Wnt pathway regulator with its different domains responsible for 
different functions [105]. Ptk7 was recently shown to modulate Wnt signalling activity via 
Lrp6 [64]. In HEK293 cells, PTK7 depletion by shRNA strongly inhibited LRP6 activation of 
β-catenin. Ptk7-depletion by MO caused a significant reduction of ectopically and 
endogenously expressed Lrp6 protein levels in Xenopus. Phenotypes of morphants of Lrp6 and 
Ptk7 are very similar. Lrp6 is also similar to Ptk7 in rescuing the neural tube closure 
phenotype caused by overexpressing Wnt5 or Wnt11. Ptk7 was also shown to physically 
interact with different Lrp6 constructs as long as they have the transmembrane domain which 
leads to the hypothesis that Ptk7 modulates Wnt signalling activity by binding and stabilizing 
Lrp6. 
 
Combining all the studies above, Ptk7 was shown to be very important modulator of 
both canonical and non-canonical Wnt pathways and represents a strong candidate gene for 
NTDs in humans.  
 
1.4.5 PTK7 and other related genes   
Cdx genes encode transcription factors controlling anterior-posterior patterning via 
integration of posteriorizing signals from retinoic acid and Wnt-canonical pathways [106]. 
They mediate neural tube closure through transcriptional regulation of Ptk7 [107]. Cdx1 and 
Cdx2 double knock-out mice (DKO) showed the most severe NTD craniorachischisis. The 
observed defects in axis elongation and in somite morphology in these mutants were similar to 
the Ptk7-null mutant but not the Vangl or Scribble mutants. This is further supported by the 
fact that Ptk7 expression was downregulated at E7.5 in Cdx1/2 DKO mutants. In addition, 
ChIP (chromatin immunoprecipitation) analysis revealed that the 5’ upstream promoter of 
Ptk7 is responsive to the transcription factors Cdx1 and Cdx2.  Combining all these data, Ptk7 
is further implicated in the occurrence of NTDs.  
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Ptk7 was also demonstrated to be the primary cleavage target of the MT1-MMP 
(membrane type-matrix metalloproteinase) which cleaves ECM (extracellular matrix) proteins, 
initiates activation of soluble MMPs, and controls the functionality of cell adhesion and 
signalling receptors accompanied with other receptors including CD44. By reducing the 
expression of MT1-MMP in zebrafish using a MO, a body length reduction associated with 
PCP defects was observed and accumulation of full length Ptk7 in the 2-3 day old embryos 
was detected. A genetic interaction between Ptk7 and MT1-MMP was shown by co-injections 
of low, sub-threshold dosages of MT1-MMP and Ptk7 MO causing a synergistic effect on the 
CE phenotype [108].  
 
In another cell migration and differentiation process which is called neural crest 
migration, Ptk7 precipitated with PlexinA at the gastrulation stage in Xenopus. Co–injection of  
ptk7 aggravated the neural crest defects resulting from Plexin A injection alone [109]. Ptk7 
was also shown to be needed for the facial branchiomotor (FBM) neuron migration. In E12.5 
Ptk7 chz mutants, FBM neurons failed to migrate caudally [110]. 
 
Even though Ptk7 was implicated in the regulation of epithelial morphogenesis and 
PCP through modulation of the cytoskeleton, the underlying mechanism is not yet known. One 
possible pathway was raised and proven by the same group who first linked Ptk7 to NTDs 
[111]. The proto-oncogene tyrosine-protein kinase Src is traditionally considered to have an 
important role in cancer development. Endogenous Src and Ptk7 formed a complex in co-
immunoprecipitation (coIP) experiments, and this interaction was dependent on the Ptk7 
cytoplasmic domain. The glutathione S-transferase (GST) pull-down assay was further used to 
confirm this direct interaction. After testing this interaction with different domains of Src, 
Ptk7 was shown to directly interact with the SH3 domain of Src.  The tyrosine kinase domain 
of Ptk7 is phosphorylated by active Src and then the interaction is fortified by direct 
interaction between this phosphorylated domain and the SH2 domain of Src.  Reduced gene 
expression of Ptk7 using short hairpin RNAs (shRNAs) in MDCK (Madin-Darby canine 
kidney) cells causes changes in cell shape from high and small apical surface to short and an 
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increased apical surface. The distribution of ROCK2 and the cytoskeletal proteins myosin IIB 
and actin was also affected in Ptk7-depleted MDCK cells compared to controls. Src-EGFP 
rescues all those phenotypes caused by Ptk7 reduced expression. In conclusion, Ptk7 can 
regulate cell shape changes through Wnt signalling and/or interaction with Src in epithelial 
cells. Whether these two functional aspects of Ptk7 occur simultaneously or at different 
developmental stages or in different tissues remain unclear.  
  
1.5 The Zebrafish Model for studies of convergent 
extension 
1.5.1 Advantages of the zebrafish model 
Zebrafish is recognized to be a good animal model to research developmental disorders 
mainly because of the following characteristics: 
a) It is evolutionally closer to humans than Drosophila and C. elegans. 
b) The genome of zebrafish was sequenced and is available publically at http://zfin.org/.   
b) It has a relatively short new generation producing period. It only takes 3-4 months 
for the larvae to mature to produce a new generation. 
            c) More eggs from the same batch can be obtained compared with mice: around 200 
eggs can be obtained from two fish every two weeks.  
d) During all of the early stages of development, the embryo growing outside of 
mother body is transparent which allows us to observe the phenotype without interfering with 
the normal progress. 
e) Availability of in vitro fertilization techniques and easier manipulation of 
microinjection compared to mouse. 
f) The cost of keeping the strain and producing new strains is relatively low.  
1.5.1 Zebrafish development 
Thanks to its inherent properties like in vitro fertilization and transparency of eggs, 
zebrafish development has been well studied and described in detail.  Seven broad periods of 
development are defined: zygote, cleavage, blastula, gastrula, segmentation, pharyngula and 
hatching periods [112]. 
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The zygote period is the period from fertilization to the formation of one cell at the 
animal pole. It occurs around 40 minutes post-fertilization in standard zebrafish incubation 
conditions. In this period, the chorion swells and lifts away from newly fertilized eggs and the 
non-yolky cytoplasm begins to stream toward the animal pole to form the first cell. In most 
cases, this is the best time for injection so that the injected content in yolk will diffuse to the 
cell. 
 
The cleavage period is the period in which one cell will be divided six times via 
meroblastic cytoplasmic division. It occurs around until two hours post-fertilization. The 
blastomeres remain interconnected by cytoplasmic bridges before the fourth cleavage. From 
the fourth to the sixth cleavage, more and more blastomeres will have complete boundaries 
isolating them from others. In this period, eventual axes of body symmetry cannot be predicted 
from the orientation of the cleavage. 
 
The blastula period is a period when the blastodisc begins to look like a ball. It lasts 
between 2.25 to 5.25 hours post-fertilization. Important processes occur during this blastula 
period: the embryo enters mid blastula transition (MBT), the yolk syncytial layer (YSL) forms, 
and epiboly begins.  
 
The gastrula period is a period in which epiboly continues to finally cover all the yolk 
and finally the tail bud forms. It occurs between 5.25 to 10 hours post fertilization. During this 
period, a series of morphogenetic cell movements occur, producing the primary germ layers 
and the embryonic axis. CE movements of cells starting from shield stage play an important 
role in the epiboly and axis formation. Epiboly is a cell movement characterized as being a 
thinning and spreading of cell layers to finally engulf the whole yolk. According to the 
percentage of yolk coverage in lateral view, different epiboly stages are named. For example, 
50% percent epiboly means the blastmere margin is in the middle between animal pole and 
vegetal pole. 
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The segmentation period is the period during which the somites develop, the primary 
organs start to become visible and the first body movements appear. It occurs around 24 hours 
post fertilization. 
 
The pharyngula period is a period during which the pharyngeal arches develop 
rapidly. It occurs around 2 days post-fertilization. The embryos are morphologically distinct 
from other vertebrates. 
 
The hatching period refers to the period when the embryo will escape from the 
chorion. It occurs around the end of the 3rd day of post-fertilization. During this period, 
rudiments of the pectoral fins, the jaws, and the gills develop rapidly. 
 
1.5.2 CE in zebrafish  
Neural tube formation in zebrafish implicates primary neurulation in the head and 
trunk and secondary neurulation in the tail as mentioned above in section 1.2.4.   CE, as one of 
the very important processes for gastrulation and neurulation in zebrafish, happens after 50% 
epiboly when the cells surrounding the yolk migrate from ventral and lateral to dorsal regions. 
It consists of convergent and extension movements in different germ layers as demonstrated in   
Fig. 9. At the early blastula stage, cells located in the animal pole start to migrate to the 
vegetal pole. The cells at the blastoderm margin start to involute and form the prospective 
endoderm and mesoderm under the superficial layer of the prospective ectoderm. As 
endoderm and mesoderm originate from the same group of cells, the mechanisms involved in 
the separation of these two layers is not fully understood. These two layers will be discussed 
as combined in the following paragraphs.  
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1.5.2.1 PCP genes and convergent extension in zebrafish  
Mutations in Wnt11 are responsible for the zebrafish mutant slb (silberblick) [114]. In 
zebrafish, Wnt11 expression is first detected in the germ ring at the shield stage and later in the 
paraxial head mesoderm and in the neuroectoderm at 90% epiboly.  The main phenotype of slb 
 
 
Fig. 9. Diagram for CE in zebrafish during gastrulation. At early gastrulation, 
mesendodermal cells form after involution from blastoderm margin cells and migrate 
mainly to the animal pole (A). Ectodermal cells basically migrate from the animal pole 
to the vegetal pole (D). At later stages, while migrating from the margin to the animal 
pole, ventro-lateral mesendodermal cells at the same time migrate to the dorsal midline 
(B). Overlying ectodermal cells continue the epiboly process and at the same time 
migrate from basal later to dorsal midline (E).  At the end of gastrulation, 
mesendodermal cells continue migrating to the dorsal midline (C). Ectodermal cells 
elongate along the antero-posterior axis (F). All embryos were in lateral view with 
animal pole on the top and vegetal pole on the bottom. Modified from [113]. 
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mutant is cyclopia resulting from the abnormal extension of axial tissues. Even though it is not 
expressed in axial tissues, its expression in paraxial mesoderm is required for antero-posterior 
extension instead of medial-lateral convergence by affecting the mesoderm intercalation.  Due 
to this extension defect of the axial mesoderm, the anterior end of the axial mesoderm cannot 
pass the edge of the ventral central nervous system which results in the fusion of the eyes 
(cyclopia).  In these mutants, the body length is not significantly different from the wild type 
fish at later stages. 
 
Ppt/wnt5 (pipetail) is maternally provided, and zygotic expression of Wnt5 is 
detectable in the germ ring at shield stage (remains at 50% epiboly, anterior-posterior and 
dorsal-ventral axes are detectable for the first time), and in the posterior paraxial 
mesendodermal cells at later gastrulation stage [115]. Due to the difference in their expression 
pattern, the Wnt5 mutants mainly has CE defects in the posterior axial region while the defects 
in Wnt11 mutant disperse along the whole antero-posterior axis. There is almost no effect on 
the extension at the anterior end of axis in Wnt5 mutants which corresponds to the lack of 
cyclopia phenotype. 
 
Knypek (kny) is a zebrafish mutant carrying mutations in the gene glypican-4 which 
encodes for a heparan sulfate proteoglycan.   It functionally interacts with slb in inducing the 
CE phenotypes like cyclopia [116]. This interaction was also seen with trilobite or tri (a 
homologue of Vang in zebrafish) [117] . It is important to note that although kny, slb and tri 
are mutants that all have the common convergent extension defects, the extent of these defects 
really differs among each other. The kny mutant shows the most severe reduction while the slb 
mutant shows only a slight reduction at 1dpf (day post-fertilization).  For cyclopia, the slb 
mutant has the highest percentage while this phenotype is infrequent in kny mutants. 
 
Trilobite is a zebrafish mutant of the PCP core gene Stbm/Vang that activates this 
pathway.  The tri mutation in Stbm/Vang causes cell shape changes in the mesodermal and 
ectodermal cells and a reduction in the midline oriented migrating speed at the later 
gastrulation stage.  This results in an obvious body length reduction at 1dpf.  Cyclopia is also 
 33 
 
observed in this mutant with a much lower frequency than in slb mutant. Tri also controls 
effective migration of branchiomotor neurons towards posterior rhombomeres [118]. Both 
reduced expression with MO against tri and ectopic overexpression of this gene can induce the 
same phenotype.  Overexpression of hVANGL1 in zebrafish gives the same CE phenotype [42]. 
 
Both gain- and loss-of function of another PCP gene Pk1 cause CE defects [119]. 
Overexpression of a membrane-targeted intracellular domain of Celsr also causes a CE defect 
during zebrafish gastrulation [120]. 
 
1.5.2.2 Other genes mediating CE in zebrafish 
Stat3 is a transcription factor responding to a variety of cytokines and growth factors. 
Zebrafish Stat3 is activated by maternal Wnt/β-catenin pathway in dorsal regions shortly after 
maternal blastula transition [121]. Reducing expression of this gene by MO shows CE defects 
like a short antero-posterior axis and mis-positioning of the head. Another study showed that 
Stat3 affect the anterior movements of axial mesoderm and dorsal movements of non-axial 
mesoderm [122] . 
 
BMP signalling, FGF signalling and canonical Wnt signalling are all needed at some 
point in gastrulation to execute the CE process cooperatively [123]. 
 
1.5.2.3 PTK7 and CE in zebrafish 
Knockdown of zebrafish ptk7 by a zinc-finger nuclease (ZFN) gene targeting approach 
created a transgenic line with loss-of-function of ptk7. Heterozygous or homozygous mutants 
obtained from crossing of heterozygotes have no obvious phenotype while maternal-zygotic 
MZPtk7 homozygous mutants show a very severe CE phenotype and body length reduction. 
Co-overexpression of Ptk7 with Wnt5b showed that Ptk7 exacerbates the CE phenotype 
caused by Wnt5b like cyclopia and body length reduction [94]. Interestingly, the CE 
phenotype observed in MZptk7 mutants can be rescued by injection of the RNA products of 
membrane anchored extracellular Ptk7 [94]. 
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2 Research Project 
2.1 Significance and rationale  
 NTDs are one of the most common congenital defects with a high incidence of 1-2 
per 1000 births. They cause a heavy burden to both affected families and society. Although 
periconceptional folic acid supplementation has significantly reduced the frequency of NTDs 
by around 70%, roughly 30% of NTDs appear resistant to folic acid and these conditions still 
affect thousands of families each year. Epidemiological studies and data derived from animal 
models demonstrated a multifactorial etiology where environmental and genetic factors 
interact with each other to modulate their incidence and severity even though the underlying 
molecular and cellular pathological mechanisms remain poorly understood. Understanding the 
mechanisms underlying their etiology is a prerequisite to prevent their occurrence. The 
identification of NTD causing gene(s) would help investigate new aspects of the disease 
mechanisms and would certainly have a substantial impact on the best approach to choose for 
the development of new counseling and preventive strategies.  
 
Genetic studies in animal models and human cohorts have demonstrated an important 
role for the PCP pathway in NTD pathogenesis. For some PCP members, such as Vangl and 
Prickle, their roles in human NTDs patients have been well documented [41, 45]. 
 
Ptk7 is a new PCP member in which mutations were shown to cause NTDs in two 
mouse lines [35, 96] and hence its orthologue represents a strong candidate for NTDs in 
humans. The role of PTK7 in human NTDs has not been yet studied.  As NTDs are 
etiologically complex, large human cohorts are needed to investigate the individual 
contribution of predisposing genes. Here, we recruited a large human NTD cohort and 
investigated the genetic contribution of PTK7 to the occurrence of NTDs in this cohort.  
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2.2 Hypothesis and objectives 
 
Hypothesis: Mutations in PTK7 contribute to the pathogenesis of human NTDs.  
 
Objective 1: Sequence analysis of the coding region of PTK7 in a well characterized cohort of 
NTD patients and controls. 
 
Objective 2: Genetic and bioinformatics validation of novel rare variants identified in PTK7 
in NTDs. 
 
Objective 3: Functional validation of novel rare variants identified in PTK7 in NTDs using a 
zebrafish model.  
 
2.3Material and Methods  
2.3.1 Patients and controls 
A cohort of 473 NTDs patients was recruited for this study. A total of 391 patients 
were recruited at the Spina Bifida Center of the Gaslini Hospital in Genova in collaboration 
with Dr. Valeria Capra and 82 patients were recruited at the Spina Bifida Center in Saint-
Justine hospital in Montreal. Information on this cohort is included in Table 1.  
 
Briefly, all patients (N=473) were affected with non-syndromic or isolated NTDs and 
were diagnosed according to Tortori-Donati classification [47]. The distribution of the major 
NTD forms in this cohort was as follows: 2% cranial, 46% open spinal and 52% closed spinal.  
Myelomeningocele was the major NTD present in this cohort at a frequency of 45%. The 
majority of NTD patients included in this cohort (97%) were white Caucasians. 19% of 
patients had a positive family history (Table 1). 
 
The control group consisted of 639 ethnically-matched individuals including 433 
Italian people and 206 Caucasians people of French-Canadian origin. Samples from patients 
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and controls were collected with the approval of the local ethics committees and written 
informed consent was obtained from all participating individuals. 
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Table 1. Characteristics of the 473 NTDs patients 
Ethnic origin 459 Caucasian , 5 Hispanic, 3 Haitian, 4 
North-African, 2 Middle Eastern Asiatic 
Male sex (%) 44 
Mean age (yr) 2.6 
  
Cranial dysraphisms 11 
Anencephaly 1 
Cephalocele 10 
  
Open spinal dysraphisms 215 
Myelomeningocele 214 
Myelocele 1 
  
Closed spinal dysraphisms 247 
Lipomyelomeningocele 37 
Lipomyeloschisis 34 
Terminal myelocystocele 1 
Meningocele 12 
Lipoma 48 
Tight filum terminale 17 
Dermal sinus 3 
Diastematomyelia 17 
Caudal Regression Syndrome 61 
Unknown type 17 
 
Table 1. haracteristics of the 473 T s patients 
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2.3.2 Re-sequencing of PTK7 
The genomic structure of PTK7 (ENSG00000112655) was determined using the NCBI 
(http: //www.ncbi. nlm.nih.gov) and Ensembl (http://www.ensembl.org) public databases. 
Most recognized disease-causing mutations affect the protein-coding regions [124] and hence 
our screening strategy focused on the coding exons of PTK7. Primers flanking the exons and 
exon-intron junctions were developed to amplify the coding region and exon-intron junctions 
by PCR (polymerase chain reaction). Primers and corresponding exons are listed below in 
Table 2. Direct dye terminator sequencing of PCR products was carried out using the ABI 
Prism Big Dye Systems at the McGill University and Genome Quebec Innovation Center 
(Montréal, Québec, Canada). Samples were run on an ABI 3700 automated sequencer  and 
analyzed using the SeqMan® sequence assembly and SNP discovery software (from 
DNASTAR®). Variants were confirmed by PCR and sequencing of the same patient.   
 
2.3.3 Genetic validation of rare PTK7 mutations  
Rare mutations (minor allele frequency ＜ 1%) identified in PTK7 in NTD patients 
were genetically validated by: a) investigating their presence in the ethnically-matched 
controls and in the dbSNP (http://www.ncbi.nlm.nih.gov/snp), and The Exome Aggregation 
Consortium (ExAC) (http://exac.broadinstitute.org/) databases.; b) segregation in other family 
members when available and c) investigation of their de novo status when both parents were 
available.  
 
2.3.4 Pathogenic effect prediction using bioinformatics  
The possible effect of these mutations on the protein function was predicted by 
PolyPhen-2 (Polymorphism Phenotyping; http://genetics.bwh.harvard.edu/pph2/dokuwiki/start) 
and SIFT (Sorting Intolerant From Tolerant; http://sift.jcvi.org/).  Polyphen predicts possible 
impact of an amino acid substitution on the structure and function of a human protein using 
straight-forward physical and comparative considerations. SIFT predicts whether an amino 
acid substitution affects protein function. SIFT prediction is based on the degree of 
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conservation of amino acid residues in sequence alignments derived from closely related 
sequences, collected through PSI-BLAST [125]. 
 
2.3.5 Expression constructs 
The human PTK7-pBluescriptR clone was obtained from Open Bio-systems 
(http://dharmacon.gelifesciences.com/) and used as a template to clone the full length ORF of 
Table 2 Primers for sequencing of hPTK7 
exons forward_seq reverse_seq amplicon_size
1 GGACTCGGAGGTACTGGGC GAGCCTCTCCACTACTCCAGG 387 
2 ACACCTGCACTTACTGGACG TGATAAATGCATTCTGCCTG 540 
3 TTCCTTGTGTCTGTTGGCAC TGAAGAGCACTGTGGTGGTG 356 
4-5 CTTCCTCAGGCCGTTTCTC AAAAGCAAAACATTCAACTGTGTC 702 
6 TCAGCTTCCTTCTCTCTGCC CCTACTCCCAGCATCCTTTTC 416 
7 AGAGGATATGCAGAGGGCTG ATTGGGAGCATAGTGGGACC 689 
8-9 GGAAACTCCTGCCATCTGAG TTTCAGCAGAGGGTGGGTAG 690 
10 GAGCCAGCATGTCTTGGG CTATACATCAGCCCTGCACTG 387 
11-12 AGTTTGGACTTTGCCTGTGG GATCACCAGGGAGCCATTC 668 
13 ATCCTGGACCCCACCAAG CAGCAGCATGGTGAGACG 391 
14 TGTTAAAGCCAGTGAAGGTGG TCCAGGACCCAGCAACAG 461 
15 GAGGCCCCATGAAAGCAAAAATCC ACGAAGGGCAGTGAATAACAGG 653 
16 AGAACCGGGTCTCGTGC GTAACAGCAGGCAGGTGAGG 497 
17 TTTAAAGTTCTGCACTCCCAG CAGTAACACATGTGAAGTTCTTACC 378 
18 AGGAAGCTGAGGCTGTTGTG CTATCCCAGGCCCTCCAG 422 
19 CGCATGTGACCAATTTCTTG GGTTGTATCTGTGTGCCTGC 447 
20 CCAGCATTGCCCCAGAG ACCTCAGCAATGCCTGTTG 411 
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PTK7 in pCS2+ using the SLIC (sequence- and ligation-independent cloning) protocol [126] 
Primers are depicted in Table 3. This master mix for PCR was as follows: 1.0 unit of Pfusion 
polymerase, 1xGC buffer, 1.5 ul DMSO and 1X Betaine and 0.5 uM final concentration of 
forward and reverse primers in 50ul reaction volume. This PCR was conducted under the GC 
cycle: 98°C 1 minute, 98°C 10 seconds, 63°C 25 seconds, 70°C 2 minutes, 35 cycles. The 
pCS2+ vector was digested with BamHI and EcoRI. The PCR product and digested vector 
were purified using gel extraction kit (Bio Basic Inc) and then digested both with T4 
polymerase in the absence of dNTP to produce the 5’ overhangs that are homologous between 
the vector and inserts. The reaction was stopped by adding 1/10 volume of 10 mM dCTP. A 
ligation reaction was done using NEB ligase buffer in 37°C for 30 minutes. This is followed 
by transformation of the ligation product into XL-10 gold cells (Agilent Technology). 
Sequences of all constructs was verified by Sanger sequencing.  
 
Human mutations were introduced in pCS2- PTK7 using the protocol of site-directed 
mutagenesis. Primers used for mutagenesis are described in Table 3. All mutant constructs 
were verified by Sanger sequencing. 
 
2.3.6. In vitro transcription 
Capped mRNA for each of the pCS2+ expression constructs was obtained by in-vitro 
transcription using the mMESSAGEmMACHINE® SP6 Kit according to the supplied 
protocol (Ambion). DNA was linearized with the restriction enzyme NotI and precipitated by 
ethanol in the presence of NH4 acetate. RNA synthesis was conducted with the presence of: 
600 ng of linearized DNA, 2 ul Enzyme Mix，1x NTP/CAP and 1x reaction buffer at 37°C 
for 2.5 hours. LiCl precipitation was used to collect the RNA. RNA was dissolved in RNAase 
free water and titrated. 
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2.3.7 Zebrafish Maintenance, mRNA and morpholino injection  
Longfin zebrafish (Danio rerio) were raised from a colony maintained according to 
established procedures in compliance with guidelines set out by the Canadian Council for 
Animal Care. For the overexpression experiments, 400 pg capped message RNA were injected 
in one-cell stage zebrafish embryo. At 48 hpf (hours post-fertilization), the fish injected with 
RNA were dechorionated and photographed.  Body length was measured with ImageJ.  
 
2.3.8 Statistical analyses 
 For the distribution of rare variants in NTDs patients compared to controls, Chi-
Square test was used. For the functional validation in zebrafish, cluster analysis was done 
using the SSPS statistics software. In wild-type hPTK7 and mutant injected embryos, two 
cluster centroids were identified with mean body length ratios of 0.928 (grade 1: mildly 
affected) and of 0.531 (grade 2: severely affected), respectively. Then k-means clustering with 
classification was used to classify all additional cases from other experimental groups based 
Table 3. Primers for cloning and mutagenesis 
Clone name Method Forward Primer     5’-3’ Reverse Primer      5’-3’ 
hPTK7-pCS2+ SLIC TTGTTCTTTTTGCAGCCACCATG
GGAGCTGCGCGGGGATC 
TATAGTTCTAGAGGCTCGAGTCACGG
CTTGCTGTCCACGG 
hPTK7-I121M-pCS2+ Mutagenesis CGCCTCCTTCAACATGAAATGG
ATTGAGGCA 
TGCCTCAATCCATTTCATGTTGAAGG
AGGCG 
hPTK7-V291I-pCS2+ Mutagenesis CTGCTGCTGACCCAGATCCGGC
CACGCAATG 
CATTGCGTGGCCGGATCTGGGTCAGC
AGCAG 
hPTK7-P345L-pCS2+ Mutagenesis GTGTGACCTGCCTTCTCCCCAAG
GGTCTGCC                          
GGCAGACCCTTGGGGAGAAGGCAGG
TCACAC 
hPTK7-G348S-pCS2+ Mutagenesis TGCCTTCCCCCCAAGAGTCTGCC
AGAGCCCA 
TGGGCTCTGGCAGACTCTTGGGGGG
AAGGCA 
hPTK7-G775S-pCS2+ Mutagenesis ACCAGCTTGGGCTCCAGCCCCG
CGGCCACCA  
TGGTGGCCGCGGGGCTGGAGCCCAA
GCTGGT 
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on the original cluster centroids. A Chi-square test was used to analyze the difference in 
distribution of the clusters among the experimental groups. 
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2.4 Results and Discussion 
2.4.1 Results 
We have identified 6 rare (MAF<1%) missense mutations in PTK7 in 6 NTD patients, 
two of which were novel and were absent in all 639 ethnically-matched controls and also 
absent from dbSNP and ExAC databases: p.Gly348Ser (c.1042G>A) and p.Gly775Ser 
(c.2323G>A). Three other rare missense mutations found in two NTDs patients were absent in 
ethnically matched controls but present in dbSNP and ExAC databases:  p.Ile121Met 
(c.363C>G), p.Val291Ile (c.871G>A) and p.Pro345Leu (c.1034 C>T). One rare mutation, 
p.Pro545Arg (c.1634C>G) was present in one control while absent in all public databases 
(Table 4).   
 
The potential pathogenic impact of all six rare missense variants identified in PTK7 in 
NTD patients was first evaluated in view of a) the degree of evolutionary conservation of the 
affected residue in the PTK7 protein family; b) the nature of the amino acid replacement and 
its possible impact on protein function; and c) possible co-segregation in additional family 
members (when available).   
 
The variant p.Gly348Ser was identified in a 26-year-old Caucasian-Italian male 
diagnosed with lumbosacral myelomeningocele, Chiari II associated hydrocephalus. This 
mutation was transmitted by the mother and is shared also by one unaffected sister. It was 
absent from all controls analyzed and public databases. This variant is located in the 
extracellular Ig-like C type 4 domain (Fig. 10A). Glycine at position 348 is absolutely 
conserved among species analyzed (Fig. 10B). Replacement of a glycine with serine 
significantly reduces the hydrophobicity at this position and is considered a non-conservative 
change. This variant is predicted as probably damaging by Polyphen and tolerant by SIFT 
(Table 4).   
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Ig-1: 31-120; Ig-2:128-218; Ig-3:225-317; Ig-4:319-407; Ig-5:412-497; Ig-6: 503-586; Ig-7:578-
680 ; TM:705-725; Inactive PKD:796-1066. 
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 Fig. 10. A) A schematic diagram showing the approximate distribution of the six rare 
variants identified in PTK7 in NTDs. B) Partial alignments of Ptk7 orthologues in 
humans, chimpanzee, dog, cow, mouse, chicken and zebrafish. The PTK7 variants found 
in NTD patients affect conserved residues (indicated by arrows). Accession numbers: 
Human PTK7: NP_002812.2; Chimpanzee Ptk7:XP_518486.2; Dog Ptk7: XP_538929.2; 
Cow Ptk7: NP_001179894.1; Mouse Ptk7: NP_780377.1; Chicken Ptk7:NP_001026206.1; 
Zebrafish Ptk7: AGT63300.1 
 
 
The variant p.Gly775Ser was detected in a 24-year-old Caucasian-Italian female 
diagnosed with caudal agenesis type II combined with absence of the coccyx and fibrolipoma 
of the filum. This mutation was absent from the patient’s father, from controls and public 
databases.  DNA from other family members was unavailable. As the only variant mapping to 
the intracellular part of the protein (Fig. 10A), glycine is highly conserved among species 
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analyzed except chicken where it is replaced by serine (Fig. 10B). Replacement of glycine 
with serine affects the hydrophobicity at this position. This variant was predicted by PolyPhen 
and SIFT to be benign and tolerant, respectively (Table 4). 
 
The variant p.Ile121Met was detected in an 18-year-old male Caucasian-Italian patient 
diagnosed with myelomeningocele which is the most common form of open spina bifida. 
Detailed clinical information and DNA from family members were unfortunately not available 
for this patient. This variant was present in dbSNP (rs370537004 with undetermined MAF) 
and ExAC (allele frequency of 1.7 x10-5). This mutation is located immediately after the Ig 
like domain 1 of the protein (Fig. 10A) and affects a highly conserved isoleucine among all 
species (Fig. 10B). The hydrophobicity of Ile121 is not significantly affected by a methionine 
substitution; however, the latter does contain a sulphur atom that could affect the binding 
characteristics of the protein.  This variant is predicted to be probably damaging by PolyPhen 
and intolerant by SIFT (Table 4).   
 
The variant p.Val291Ile was identified in an 11-year-old Caucasian-Italian female 
diagnosed with lipomyelomeningocele which is a closed form of NTDs. The patient suffered 
from lipomyeloschisis associated to sacral schisis and hydromyelia from L3 to L5.  The 
parents do not have any apparent form of NTDs. However, a paternal aunt of the proband was 
diagnosed with congenital scoliosis, and another maternal second-degree cousin was 
diagnosed with scoliosis and schisis at S1. This mutation was not present in the mother and the 
father DNA was not available and hence we could not determine if this mutation occurred de 
novo. The p.Val291Ile variant was detected in ExAC although with a very rare allele 
frequency of 1.6 x10-5. It is located in Ig like domain 3 (Fig. 10A) and affects a highly 
conserved valine residue among all species analyzed (Fig. 10B). Both valine and isoleucine 
are hydrophobic amino acids; however, a substitution with isoleucine introduces a bulky side 
chain, which may have structural or functional consequences. This mutation was predicted by 
PolyPhen and SIFT as probably damaging and intolerant, respectively (Table 4).  
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Table 4. Rare single nucleotide variants identified in PTK7 in NTDs. 
SNVa Amino acida Freq. in 
patients 
(n=473) 
Freq. in 
controls 
(n=639) 
Freq. in 
dbSNP 
Freq. in 
ExAC 
Polyphenb SIFTb
c.363C>G p.Ile121Met 1 MMC 0 Unknown 1.6x10-5 + + 
        
c.817G>A p.Val291Ile 1 LipoMMC 0 0 1.6x10-5 + + 
        
c.1034C>T p.Pro345Leu 1 MMC 0 0.0012 7.8x10-4 - - 
        
c.1042G>A p. Gly348Se 1 MMC 0 0 0 + - 
        
c.1634C>G p.Pro545Arg 1 MMC 1 0 0 + - 
        
c.2323G>A p.Gly775Ser 1 CA 0 0 0 - - 
        
aThe SNV and amino acid numbering systems are based on PTK7 cDNA and protein sequence 
with the accessions AF531868.1 and AAN04862.1 respectively. 
bPolyphen: +, probably or possibly damaging;  –, benign; SIFT:+, not tolerated; -, tolerated. 
Abbreviations: CA, caudal agenesis; Freq., frequency; LipoMMC, lipomyelomeningocele; MMC, 
myelomeningocele; SNV, single nucleotide variant. 
 
The variant p.Pro345Leu was identified in a 26-year-old Caucasian-Italian female 
diagnosed with lumbo-sacral myelocele associated to lipoma of the filum terminals and 
diastematomyelia. This mutation was not present in the mother but could not be tested in other 
family members. It was detected in dbSNP (rs143537049) and ExAc with an allele frequency 
of 0.0012 and 7.8 x 10-4 respectively. Pro345 is located in the Ig-like C type 4 extracellular 
domain (Fig. 10A). This residue is moderately conserved where it is only replaced by alanine 
in mouse and cysteine in chicken (Fig. 10B). The proline to leucine substitution is 
conservative and is predicted to be benign and tolerant by PolyPhen and SIFT, respectively 
(Table 4).  
 
The variant p. Pro545Arg was detected in a myelomeningocele patient (we do not have 
the ethnic information). Additional clinical data for this patient as well DNA from other 
family members were unfortunately unavailable. This variant was present in one ethnically 
matched control while absent from public databases. The proline residue at position 545 maps 
to the Ig-like 6 extracellular domain and is highly conserved among all species except in 
zebrafish where it is replaced by alanine with similar amino acid characteristics (Fig. 10B). 
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The substitution of a nonpolar amino acid proline by a positively charged arginine is non-
conservative.  This variant is predicted to be possibly damaging and tolerant by PolyPhen and 
SIFT, respectively (Table 4).  
 
 
Fig. 11. A) Lateral views of 48 hpf zebrafish embryos showing the various degrees of 
severity of CE defects: uninjected or wild-type-like (top), moderately affected (middle) 
and severely affected (bottom).   B) The distribution of the two clusters defined as grade 
1(wild-type to moderate ) or grade 2 (severe) with average body length ratios of 0.928 
and of 0.531 respectively in each of the experimental groups injected with each of wild-
type PTK7 and of the 6 PTK7 variants. Asterisk shows statistical significance at P<0.008. 
 
To further investigate the potential pathogenic role of rare PTK7 variants identified in 
NTDs, we used an overexpression assay in a zebrafish model that represents a well established 
model for PCP-related studies [127].  Overexpression of PCP genes (including VANGL1 and 
PK1) in zebrafish was shown to cause severe CE defects manifested mainly by a shortened 
body axis [42, 45]. Injection of 400 pg of wild-type or mutant PTK7 produced a range of 
phenotypes that varied from wild-type to mild to severely affected embryos (Fig. 11A). 
Cluster analysis identified two centroids of average body length ratios of 0.928 (grade 1) and 
of 0.531 (grade 2). Overexpression of wild-type PTK7 generated 63 % grade 1 and 37% of 
grade 2 embryos. Overexpression of each of the p.Ile121Met, p.Pro345Leu and Pro545Arg 
mutant RNAs generated less of the severely affected grade 2 embryos at P=0.017, P=0.043 
and P=0.029, respectively (Fig. 11B).  While this effect is not considered statistically 
significant after correction for multiple testing, these data suggest that these three alleles could 
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act in a hypomorphic fashion. Overexpression of the p.Gly348Ser RNA generated more of the 
severely affected grade 2 embryos, significant at P=0.004, suggesting a hypermorphic allele 
(Fig. 11B). Overexpression of either p.Val291Ile or p. Gly775Ser gave similar results as the 
wild-type PTK7 (Fig. 11B).  
 
2.4.2 Discussion 
Ptk7 was demonstrated to play an important role in regulating PCP signaling and loss-
of-function of this locus is responsible for NTDs and other epithelial malformations in mouse 
models [35, 95]. In our study, we analyzed its human orthologue in a large cohort of various 
types of open and closed NTDs and we detected six rare variants in six NTD patients, three of 
which, p.Gly348Ser, Pro545Arg and Gly775Ser were novel. Four PTK7 variants detected in 
NTDs, p.Ile121Met, p.Val291Ile, p.Gly348Ser and p.Pro545Arg, were predicted to be 
pathogenic in silico by either Polyphen or SIFT or both. All variants except p.Gly775Ser, were 
located in the extracellular domain of PTK7 which was shown to be an important regulator of 
both non-canonical Wnt/PCP and canonical Wnt/β-catenin signaling during embryonic 
development [94].  In fact, a membrane tethered extracellular domain of PTK7 was sufficient 
to rescue CE and patterning defects in maternal-zygotic (MZ) ptk7 mutant zebrafish, 
demonstrating the importance of this domain in both pathways [94]. 
 
Functional validation using an overexpression assay in a zebrafish model demonstrated 
that three of the PTK7 rare mutations detected in NTDs, p.Ile121Met, p. Pro345Leu and 
p.Pro545Arg produced less severe CE defects suggesting that they could act as hypomorphs.  
This effect lost statistical significance after the stringent Bonferroni correction for multiple 
testing. It is interesting to note that another mutation at the same site as p.Pro545Arg, 
p.Pro545Ala, was identified in a single idiopathic scoliosis patient and his father (who did not 
display spinal deformities) and was shown to be a loss of function mutation that fails to rescue 
the PCP-mediated axial extension defects of MZptk7 mutants and to inhibit the canonical 
Wnt/β-catenin activity [101]. These data demonstrate that Pro545 is important for protein 
function and substitutions at this residue are most likely pathogenic. p.Pro545Arg was also 
present in one of control, The explanation could be that this heterozygous mutation alone is 
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not sufficient to cause spinal deformities, however combined with other genetic or 
environmental factors, spinal deformities could be induced. We also demonstrated that one 
variant, p.Gly348Ser, is most likely hypermorphic since it generated a higher percentage of 
severely affected embryos that was significantly different from wild-type.   
 
PTK7 is a highly conserved protein with multiple functions during embryonic 
development and adult late-onset processes [95, 128]. In addition to its role in PCP signaling 
during gastrulation and neural tube closure, it is implicated in axonal guidance in Drosophila 
and in mediating neural crest migration and cardiac morphogenesis in vertebrates.  In human 
pathological conditions, this versatile protein plays an important role in epidermal wound 
repair and its expression is frequently deregulated in cancer [95, 128].  A most recent study 
has demonstrated that embryonic loss-of-function in zebrafish leads to vertebral anomalies 
associated with congenital and idiopathic forms of scoliosis. In the same study, a novel 
sequence variant in PTK7 with dysregulated Wnt signaling was identified in a single patient 
affected with idiopathic scoliosis, providing evidence for a pathogenic role for this gene in the 
human condition as well [101]. Remarkably, NTDs patients often show vertebral and spinal 
anomalies among them vertebral schisis, congenital scoliosis, cyphosis, lordosis, and 
shortened anterio-posterior axis of the vertebral column. In particular an Italian patient 
carrying p.V291I mutation presents with a vertebral schisis and has a strong familial history of 
congenital scoliosis. (The p.V291I behaves in vivo as wild-type protein but it could be 
interesting evaluate the effect of this variant in late onset ptk7 zebrafish mutants in spine 
morphogenesis, as done by Hayes et al. (2014).  Our findings demonstrate for the first time a 
pathogenic role of this multifunctional gene in NTD etiology in humans. Moreover, since 
PTK7 was demonstrated as an important later requirement in spine morphogenesis in animal 
models, we, in agreement with other, hypothesize that PTK7 could also play a role in the 
correct patterning and development of the anteroposterior axis of embryo.  
 
The molecular mechanisms by which PTK7 can activate the non-canonical Wnt/PCP 
pathway and simultaneously inhibit the canonical Wnt/β-catenin pathway remain largely 
undetermined. It was shown that the tyrosine kinase homology domain located in the 
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intracellular part of the protein is required for membrane recruitment of Dishevelled (Dsh), 
which is considered as a prerequisite for PCP signalling [97].  This recruitment seems to occur 
through the interaction of Ptk7 with Rack1 by its pseudokinase domain independent of 
Frizzled [98]. Interaction partners of the extracellular domain of Ptk7 have not yet been 
identified yet. Otk, the fly orthologue of Ptk7, interacts with Wnt4 and opposes canonical Wnt 
signalling in embryonic patterning. In Xenopus lysates, a deletion construct containing only 
the extracellular domain of Ptk7 was shown to selectively interact with Wnt3a and Wnt8, but 
not with Wnt5a and Wnt11 that are known inducers of non-canonical Wnt/PCP signaling. 
These data propose a model where Ptk7/Otk activates the non-canonical Wnt/PCP signaling 
by turning off the canonical signaling branch [99]. Five of the PTK7 rare mutations identified 
in our NTD cohort in this study map to the extracellular domain and hence they could affect 
Wnt/PCP signaling indirectly through an over- or under-inhibition of the Wnt/β-catenin 
canonical pathway. In particular, the variant p.Gly348Ser that behaved in a hypermorphic 
manner in the zebrafish assay would over-inhibit the canonical pathway leading to an over-
activation of the PCP pathway and subsequent defective CE. Additional tests including 
luciferase gene reporter assays for both Wnt pathways are needed to further investigate this 
hypothesis and confirm the potential pathogencity of these variants. Alternatively, these 
mutations could affect PCP signaling directly through yet to be determined PTK7 binding 
partners or ligands.  
 
2.4.3 Conclusions   
 
In conclusion, we detected five rare missense mutations in PTK7 with a potential 
pathogenic role, as predicted in silico and/or in the zebrafish overexpression assay, in 1.1% of 
the cohort analyzed. This is a very similar rate to the one reported in other screening studies of 
PCP genes in NTDs [129]. Our cohort analyzed in this study was also screened for mutations 
in other PCP genes and interestingly the patient who carried the p.Gly348Ser variant 
hypothesized to be hypermorphic carries a rare mutation in another PCP member CELSR1, p. 
Thr346Ser [130].  Note that this patient also has the published mutation FZD6*20C>T. 
Consistent with a multifactorial threshold model for NTDs, it would be interesting to test for 
genetic interactions among these two PCP variants detected in the same patient, for example 
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using a zebrafish model, to determine whether they act in combination to confer a higher risk 
for NTDs. 
 
2.4.4 Future directions 
2.4.4.1 Functional validation of PTK7 variants identified in NTDs 
Co-injection experiments of wild type hPTK7 with all mutations separately will be 
conducted to determine whether the wild type and the mutants act in opposite directions to 
each other (dominant negative) or in the same direction in PCP signaling. In addition, in vitro 
experiments like the TCF/LEF reporter Luciferase assay in HEK293 cells transfected with 
wild type hPTK7 or the identified variants will be conducted to detect the effects of these 
mutations on canonical Wnt signaling. The ATF2-Based Luciferase reporter assay will be 
used to monitor the changes of non-canonical Wnt signaling [131]. For the mutations 
p.Gly348Ser, p.Pro345Leu, p.Pro545Arg, and p.Gly775Ser, their effect on the interaction with 
their potential partners such as β-catenin, RACK1 and LRP6 will be investigated by co-
immunoprecipitation studies in vitro in HEK293 or in MDCK cell lines. 
 
Knockdown/rescue experiments will be conducted in zebrafish using MO, an 
established technology that is the method of choice (preferred over RNAi) in zebrafish. To 
mimic completely the loss-of-function of a gene, a stable transgenic line will be produced by a 
new genome editing method CRISPR (clustered, regularly interspaced, short palindromic 
repeats)/Cas9(CRISPR associated system) [132].  
 
2.4.4.2 Identification of more genes predisposing to NTDs 
The complex etiology of NTDs involves the interaction of many genetic and 
environmental factors whose number and identity remain largely unknown. The use of 
innovative and powerful DNA sequencing methods to expand the genetic screen from one 
signaling pathway (PCP) to the entire coding genome by re-sequencing all the coding exons of 
affected individuals will increase the potential to systematically search and identify additional 
rare pathogenic mutations in both known and novel genes.  Finally we are heading to a “whole 
 52 
 
genome” sequencing era where new sequence technologies will allow whole genome mutation 
analysis including regulatory mutations without a priori assumption regarding genes function.  
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